<?xml version="1.0" encoding="UTF-8"?>
<p>Madagascar and its neighboring islands in the Western Indian Ocean regions are known as biodiversity hotspots [
 <xref rid="B8-pharmaceuticals-13-00303" ref-type="bibr">8</xref>]. Undoubtedly, untapped endemic plant species from these niche areas broaden the structural variation of novel chemotypes [
 <xref rid="B9-pharmaceuticals-13-00303" ref-type="bibr">9</xref>,
 <xref rid="B10-pharmaceuticals-13-00303" ref-type="bibr">10</xref>]. The tropical forest of Madagascar was once acknowledged as a fertile source of economically valuable plants with pharmacologically active ingredients [
 <xref rid="B11-pharmaceuticals-13-00303" ref-type="bibr">11</xref>]. Indeed, the anticancer drugs vinblastine and vincristine were derived from the Madagascan endemic 
 <italic>Catharanthus roseus</italic> (Apocynaceae) [
 <xref rid="B12-pharmaceuticals-13-00303" ref-type="bibr">12</xref>]. Certainly, the market value of vincristine alone was estimated to be USD 15 million per kilogram, in the year 2016 [
 <xref rid="B13-pharmaceuticals-13-00303" ref-type="bibr">13</xref>].
</p>
